The global market for RNA Interference Therapy was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

RNA Interference Therapy, or RNAi Therapy, is a cutting-edge medical approach that utilizes small RNA molecules to selectively silence or regulate targeted genes. This therapeutic method involves introducing synthetic small interfering RNA (siRNA) or microRNA (miRNA) into cells, triggering a natural biological process that inhibits the expression of disease-related genes. RNA Interference Therapy shows promise in treating various conditions, including genetic disorders, viral infections, and certain cancers. By leveraging the specificity of RNA molecules, this therapy holds the potential to revolutionize precision medicine by addressing the root causes of diseases at the genetic level, promoting targeted and personalized treatment strategies.

The RNA Interference Therapy industry is experiencing a dynamic shift towards precision medicine and targeted treatments. Advancements in understanding genetic mechanisms have fueled a surge in RNAi research and development. The trend emphasizes personalized therapies, with a focus on tackling specific gene-related disorders at the molecular level. Improvements in delivery systems, such as nanoparticle technologies, are enhancing the efficiency and specificity of RNA interference. The growing pipeline of RNAi-based drug candidates, especially in oncology and rare diseases, showcases the increasing interest and investment in this therapeutic approach. Overall, the industry trend leans towards unlocking the full potential of RNA Interference Therapy for precise and effective medical interventions.

This report aims to provide a comprehensive presentation of the global market for RNA Interference Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding RNA Interference Therapy.

The RNA Interference Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global RNA Interference Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the RNA Interference Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of RNA Interference Therapy Market Report

Report Metric	Details
Report Name	RNA Interference Therapy Market
Segment by Type	siRNA miRNA shRNA piRNA
Segment by Application	Cancer Treatment Hereditary Disease Infectious Disease Nervous System Disease Diseases of Immune System Cardiovascular Disease Metabolic Disease
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Silence Therapeutics, Arrowhead Pharmaceuticals, Janssen Research & Development, Sylentis, Sirnaomics, Dicerna Pharmaceuticals, Alnylam Pharmaceuticals, Silenseed, Vir Biotechnology, OliX Pharmaceuticals, Bio-Path Holdings, Suzhou Ribo Life Science
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of RNA Interference Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the RNA Interference Therapy Market report?

Ans: The main players in the RNA Interference Therapy Market are Silence Therapeutics, Arrowhead Pharmaceuticals, Janssen Research & Development, Sylentis, Sirnaomics, Dicerna Pharmaceuticals, Alnylam Pharmaceuticals, Silenseed, Vir Biotechnology, OliX Pharmaceuticals, Bio-Path Holdings, Suzhou Ribo Life Science

What are the Application segmentation covered in the RNA Interference Therapy Market report?

Ans: The Applications covered in the RNA Interference Therapy Market report are Cancer Treatment, Hereditary Disease, Infectious Disease, Nervous System Disease, Diseases of Immune System, Cardiovascular Disease, Metabolic Disease

What are the Type segmentation covered in the RNA Interference Therapy Market report?

Ans: The Types covered in the RNA Interference Therapy Market report are siRNA, miRNA, shRNA, piRNA

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global RNA Interference Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 siRNA

1.2.3 miRNA

1.2.4 shRNA

1.2.5 piRNA

1.3 Market by Application

1.3.1 Global RNA Interference Therapy Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Cancer Treatment

1.3.3 Hereditary Disease

1.3.4 Infectious Disease

1.3.5 Nervous System Disease

1.3.6 Diseases of Immune System

1.3.7 Cardiovascular Disease

1.3.8 Metabolic Disease

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global RNA Interference Therapy Market Perspective (2020-2031)

2.2 Global RNA Interference Therapy Growth Trends by Region

2.2.1 Global RNA Interference Therapy Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 RNA Interference Therapy Historic Market Size by Region (2020-2025)

2.2.3 RNA Interference Therapy Forecasted Market Size by Region (2026-2031)

2.3 RNA Interference Therapy Market Dynamics

2.3.1 RNA Interference Therapy Industry Trends

2.3.2 RNA Interference Therapy Market Drivers

2.3.3 RNA Interference Therapy Market Challenges

2.3.4 RNA Interference Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top RNA Interference Therapy Players by Revenue

3.1.1 Global Top RNA Interference Therapy Players by Revenue (2020-2025)

3.1.2 Global RNA Interference Therapy Revenue Market Share by Players (2020-2025)

3.2 Global RNA Interference Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by RNA Interference Therapy Revenue

3.4 Global RNA Interference Therapy Market Concentration Ratio

3.4.1 Global RNA Interference Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by RNA Interference Therapy Revenue in 2024

3.5 Global Key Players of RNA Interference Therapy Head office and Area Served

3.6 Global Key Players of RNA Interference Therapy, Product and Application

3.7 Global Key Players of RNA Interference Therapy, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 RNA Interference Therapy Breakdown Data by Type

4.1 Global RNA Interference Therapy Historic Market Size by Type (2020-2025)

4.2 Global RNA Interference Therapy Forecasted Market Size by Type (2026-2031)

5 RNA Interference Therapy Breakdown Data by Application

5.1 Global RNA Interference Therapy Historic Market Size by Application (2020-2025)

5.2 Global RNA Interference Therapy Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America RNA Interference Therapy Market Size (2020-2031)

6.2 North America RNA Interference Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America RNA Interference Therapy Market Size by Country (2020-2025)

6.4 North America RNA Interference Therapy Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe RNA Interference Therapy Market Size (2020-2031)

7.2 Europe RNA Interference Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe RNA Interference Therapy Market Size by Country (2020-2025)

7.4 Europe RNA Interference Therapy Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific RNA Interference Therapy Market Size (2020-2031)

8.2 Asia-Pacific RNA Interference Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific RNA Interference Therapy Market Size by Region (2020-2025)

8.4 Asia-Pacific RNA Interference Therapy Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America RNA Interference Therapy Market Size (2020-2031)

9.2 Latin America RNA Interference Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America RNA Interference Therapy Market Size by Country (2020-2025)

9.4 Latin America RNA Interference Therapy Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa RNA Interference Therapy Market Size (2020-2031)

10.2 Middle East & Africa RNA Interference Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa RNA Interference Therapy Market Size by Country (2020-2025)

10.4 Middle East & Africa RNA Interference Therapy Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Silence Therapeutics

11.1.1 Silence Therapeutics Company Details

11.1.2 Silence Therapeutics Business Overview

11.1.3 Silence Therapeutics RNA Interference Therapy Introduction

11.1.4 Silence Therapeutics Revenue in RNA Interference Therapy Business (2020-2025)

11.1.5 Silence Therapeutics Recent Development

11.2 Arrowhead Pharmaceuticals

11.2.1 Arrowhead Pharmaceuticals Company Details

11.2.2 Arrowhead Pharmaceuticals Business Overview

11.2.3 Arrowhead Pharmaceuticals RNA Interference Therapy Introduction

11.2.4 Arrowhead Pharmaceuticals Revenue in RNA Interference Therapy Business (2020-2025)

11.2.5 Arrowhead Pharmaceuticals Recent Development

11.3 Janssen Research & Development

11.3.1 Janssen Research & Development Company Details

11.3.2 Janssen Research & Development Business Overview

11.3.3 Janssen Research & Development RNA Interference Therapy Introduction

11.3.4 Janssen Research & Development Revenue in RNA Interference Therapy Business (2020-2025)

11.3.5 Janssen Research & Development Recent Development

11.4 Sylentis

11.4.1 Sylentis Company Details

11.4.2 Sylentis Business Overview

11.4.3 Sylentis RNA Interference Therapy Introduction

11.4.4 Sylentis Revenue in RNA Interference Therapy Business (2020-2025)

11.4.5 Sylentis Recent Development

11.5 Sirnaomics

11.5.1 Sirnaomics Company Details

11.5.2 Sirnaomics Business Overview

11.5.3 Sirnaomics RNA Interference Therapy Introduction

11.5.4 Sirnaomics Revenue in RNA Interference Therapy Business (2020-2025)

11.5.5 Sirnaomics Recent Development

11.6 Dicerna Pharmaceuticals

11.6.1 Dicerna Pharmaceuticals Company Details

11.6.2 Dicerna Pharmaceuticals Business Overview

11.6.3 Dicerna Pharmaceuticals RNA Interference Therapy Introduction

11.6.4 Dicerna Pharmaceuticals Revenue in RNA Interference Therapy Business (2020-2025)

11.6.5 Dicerna Pharmaceuticals Recent Development

11.7 Alnylam Pharmaceuticals

11.7.1 Alnylam Pharmaceuticals Company Details

11.7.2 Alnylam Pharmaceuticals Business Overview

11.7.3 Alnylam Pharmaceuticals RNA Interference Therapy Introduction

11.7.4 Alnylam Pharmaceuticals Revenue in RNA Interference Therapy Business (2020-2025)

11.7.5 Alnylam Pharmaceuticals Recent Development

11.8 Silenseed

11.8.1 Silenseed Company Details

11.8.2 Silenseed Business Overview

11.8.3 Silenseed RNA Interference Therapy Introduction

11.8.4 Silenseed Revenue in RNA Interference Therapy Business (2020-2025)

11.8.5 Silenseed Recent Development

11.9 Vir Biotechnology

11.9.1 Vir Biotechnology Company Details

11.9.2 Vir Biotechnology Business Overview

11.9.3 Vir Biotechnology RNA Interference Therapy Introduction

11.9.4 Vir Biotechnology Revenue in RNA Interference Therapy Business (2020-2025)

11.9.5 Vir Biotechnology Recent Development

11.10 OliX Pharmaceuticals

11.10.1 OliX Pharmaceuticals Company Details

11.10.2 OliX Pharmaceuticals Business Overview

11.10.3 OliX Pharmaceuticals RNA Interference Therapy Introduction

11.10.4 OliX Pharmaceuticals Revenue in RNA Interference Therapy Business (2020-2025)

11.10.5 OliX Pharmaceuticals Recent Development

11.11 Bio-Path Holdings

11.11.1 Bio-Path Holdings Company Details

11.11.2 Bio-Path Holdings Business Overview

11.11.3 Bio-Path Holdings RNA Interference Therapy Introduction

11.11.4 Bio-Path Holdings Revenue in RNA Interference Therapy Business (2020-2025)

11.11.5 Bio-Path Holdings Recent Development

11.12 Suzhou Ribo Life Science

11.12.1 Suzhou Ribo Life Science Company Details

11.12.2 Suzhou Ribo Life Science Business Overview

11.12.3 Suzhou Ribo Life Science RNA Interference Therapy Introduction

11.12.4 Suzhou Ribo Life Science Revenue in RNA Interference Therapy Business (2020-2025)

11.12.5 Suzhou Ribo Life Science Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Silence Therapeutics

Arrowhead Pharmaceuticals

Janssen Research & Development

Sylentis

Sirnaomics

Dicerna Pharmaceuticals

Alnylam Pharmaceuticals

Suzhou Ribo Life Science

List of Tables

Table 1. Global RNA Interference Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of siRNA

Table 3. Key Players of miRNA

Table 4. Key Players of shRNA

Table 5. Key Players of piRNA

Table 6. Global RNA Interference Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global RNA Interference Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global RNA Interference Therapy Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global RNA Interference Therapy Market Share by Region (2020-2025)

Table 10. Global RNA Interference Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global RNA Interference Therapy Market Share by Region (2026-2031)

Table 12. RNA Interference Therapy Market Trends

Table 13. RNA Interference Therapy Market Drivers

Table 14. RNA Interference Therapy Market Challenges

Table 15. RNA Interference Therapy Market Restraints

Table 16. Global RNA Interference Therapy Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global RNA Interference Therapy Market Share by Players (2020-2025)

Table 18. Global Top RNA Interference Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA Interference Therapy as of 2024)

Table 19. Ranking of Global Top RNA Interference Therapy Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by RNA Interference Therapy Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of RNA Interference Therapy, Headquarters and Area Served

Table 22. Global Key Players of RNA Interference Therapy, Product and Application

Table 23. Global Key Players of RNA Interference Therapy, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global RNA Interference Therapy Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global RNA Interference Therapy Revenue Market Share by Type (2020-2025)

Table 27. Global RNA Interference Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global RNA Interference Therapy Revenue Market Share by Type (2026-2031)

Table 29. Global RNA Interference Therapy Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global RNA Interference Therapy Revenue Market Share by Application (2020-2025)

Table 31. Global RNA Interference Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global RNA Interference Therapy Revenue Market Share by Application (2026-2031)

Table 33. North America RNA Interference Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America RNA Interference Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America RNA Interference Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe RNA Interference Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe RNA Interference Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe RNA Interference Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific RNA Interference Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific RNA Interference Therapy Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific RNA Interference Therapy Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America RNA Interference Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America RNA Interference Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America RNA Interference Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa RNA Interference Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa RNA Interference Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa RNA Interference Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 48. Silence Therapeutics Company Details

Table 49. Silence Therapeutics Business Overview

Table 50. Silence Therapeutics RNA Interference Therapy Product

Table 51. Silence Therapeutics Revenue in RNA Interference Therapy Business (2020-2025) & (US$ Million)

Table 52. Silence Therapeutics Recent Development

Table 53. Arrowhead Pharmaceuticals Company Details

Table 54. Arrowhead Pharmaceuticals Business Overview

Table 55. Arrowhead Pharmaceuticals RNA Interference Therapy Product

Table 56. Arrowhead Pharmaceuticals Revenue in RNA Interference Therapy Business (2020-2025) & (US$ Million)

Table 57. Arrowhead Pharmaceuticals Recent Development

Table 58. Janssen Research & Development Company Details

Table 59. Janssen Research & Development Business Overview

Table 60. Janssen Research & Development RNA Interference Therapy Product

Table 61. Janssen Research & Development Revenue in RNA Interference Therapy Business (2020-2025) & (US$ Million)

Table 62. Janssen Research & Development Recent Development

Table 63. Sylentis Company Details

Table 64. Sylentis Business Overview

Table 65. Sylentis RNA Interference Therapy Product

Table 66. Sylentis Revenue in RNA Interference Therapy Business (2020-2025) & (US$ Million)

Table 67. Sylentis Recent Development

Table 68. Sirnaomics Company Details

Table 69. Sirnaomics Business Overview

Table 70. Sirnaomics RNA Interference Therapy Product

Table 71. Sirnaomics Revenue in RNA Interference Therapy Business (2020-2025) & (US$ Million)

Table 72. Sirnaomics Recent Development

Table 73. Dicerna Pharmaceuticals Company Details

Table 74. Dicerna Pharmaceuticals Business Overview

Table 75. Dicerna Pharmaceuticals RNA Interference Therapy Product

Table 76. Dicerna Pharmaceuticals Revenue in RNA Interference Therapy Business (2020-2025) & (US$ Million)

Table 77. Dicerna Pharmaceuticals Recent Development

Table 78. Alnylam Pharmaceuticals Company Details

Table 79. Alnylam Pharmaceuticals Business Overview

Table 80. Alnylam Pharmaceuticals RNA Interference Therapy Product

Table 81. Alnylam Pharmaceuticals Revenue in RNA Interference Therapy Business (2020-2025) & (US$ Million)

Table 82. Alnylam Pharmaceuticals Recent Development

Table 83. Silenseed Company Details

Table 84. Silenseed Business Overview

Table 85. Silenseed RNA Interference Therapy Product

Table 86. Silenseed Revenue in RNA Interference Therapy Business (2020-2025) & (US$ Million)

Table 87. Silenseed Recent Development

Table 88. Vir Biotechnology Company Details

Table 89. Vir Biotechnology Business Overview

Table 90. Vir Biotechnology RNA Interference Therapy Product

Table 91. Vir Biotechnology Revenue in RNA Interference Therapy Business (2020-2025) & (US$ Million)

Table 92. Vir Biotechnology Recent Development

Table 93. OliX Pharmaceuticals Company Details

Table 94. OliX Pharmaceuticals Business Overview

Table 95. OliX Pharmaceuticals RNA Interference Therapy Product

Table 96. OliX Pharmaceuticals Revenue in RNA Interference Therapy Business (2020-2025) & (US$ Million)

Table 97. OliX Pharmaceuticals Recent Development

Table 98. Bio-Path Holdings Company Details

Table 99. Bio-Path Holdings Business Overview

Table 100. Bio-Path Holdings RNA Interference Therapy Product

Table 101. Bio-Path Holdings Revenue in RNA Interference Therapy Business (2020-2025) & (US$ Million)

Table 102. Bio-Path Holdings Recent Development

Table 103. Suzhou Ribo Life Science Company Details

Table 104. Suzhou Ribo Life Science Business Overview

Table 105. Suzhou Ribo Life Science RNA Interference Therapy Product

Table 106. Suzhou Ribo Life Science Revenue in RNA Interference Therapy Business (2020-2025) & (US$ Million)

Table 107. Suzhou Ribo Life Science Recent Development

Table 108. Research Programs/Design for This Report

Table 109. Key Data Information from Secondary Sources

Table 110. Key Data Information from Primary Sources

Table 111. Authors List of This Report

List of Figures

Figure 1. RNA Interference Therapy Picture

Figure 2. Global RNA Interference Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global RNA Interference Therapy Market Share by Type: 2024 VS 2031

Figure 4. siRNA Features

Figure 5. miRNA Features

Figure 6. shRNA Features

Figure 7. piRNA Features

Figure 8. Global RNA Interference Therapy Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global RNA Interference Therapy Market Share by Application: 2024 VS 2031

Figure 10. Cancer Treatment Case Studies

Figure 11. Hereditary Disease Case Studies

Figure 12. Infectious Disease Case Studies

Figure 13. Nervous System Disease Case Studies

Figure 14. Diseases of Immune System Case Studies

Figure 15. Cardiovascular Disease Case Studies

Figure 16. Metabolic Disease Case Studies

Figure 17. RNA Interference Therapy Report Years Considered

Figure 18. Global RNA Interference Therapy Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 19. Global RNA Interference Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 20. Global RNA Interference Therapy Market Share by Region: 2024 VS 2031

Figure 21. Global RNA Interference Therapy Market Share by Players in 2024

Figure 22. Global Top RNA Interference Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA Interference Therapy as of 2024)

Figure 23. The Top 10 and 5 Players Market Share by RNA Interference Therapy Revenue in 2024

Figure 24. North America RNA Interference Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. North America RNA Interference Therapy Market Share by Country (2020-2031)

Figure 26. United States RNA Interference Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Canada RNA Interference Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Europe RNA Interference Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Europe RNA Interference Therapy Market Share by Country (2020-2031)

Figure 30. Germany RNA Interference Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. France RNA Interference Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. U.K. RNA Interference Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Italy RNA Interference Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Russia RNA Interference Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Nordic Countries RNA Interference Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Asia-Pacific RNA Interference Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Asia-Pacific RNA Interference Therapy Market Share by Region (2020-2031)

Figure 38. China RNA Interference Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Japan RNA Interference Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. South Korea RNA Interference Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Southeast Asia RNA Interference Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. India RNA Interference Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Australia RNA Interference Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Latin America RNA Interference Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Latin America RNA Interference Therapy Market Share by Country (2020-2031)

Figure 46. Mexico RNA Interference Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Brazil RNA Interference Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Middle East & Africa RNA Interference Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Middle East & Africa RNA Interference Therapy Market Share by Country (2020-2031)

Figure 50. Turkey RNA Interference Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia RNA Interference Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. UAE RNA Interference Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 53. Silence Therapeutics Revenue Growth Rate in RNA Interference Therapy Business (2020-2025)

Figure 54. Arrowhead Pharmaceuticals Revenue Growth Rate in RNA Interference Therapy Business (2020-2025)

Figure 55. Janssen Research & Development Revenue Growth Rate in RNA Interference Therapy Business (2020-2025)

Figure 56. Sylentis Revenue Growth Rate in RNA Interference Therapy Business (2020-2025)

Figure 57. Sirnaomics Revenue Growth Rate in RNA Interference Therapy Business (2020-2025)

Figure 58. Dicerna Pharmaceuticals Revenue Growth Rate in RNA Interference Therapy Business (2020-2025)

Figure 59. Alnylam Pharmaceuticals Revenue Growth Rate in RNA Interference Therapy Business (2020-2025)

Figure 60. Silenseed Revenue Growth Rate in RNA Interference Therapy Business (2020-2025)

Figure 61. Vir Biotechnology Revenue Growth Rate in RNA Interference Therapy Business (2020-2025)

Figure 62. OliX Pharmaceuticals Revenue Growth Rate in RNA Interference Therapy Business (2020-2025)

Figure 63. Bio-Path Holdings Revenue Growth Rate in RNA Interference Therapy Business (2020-2025)

Figure 64. Suzhou Ribo Life Science Revenue Growth Rate in RNA Interference Therapy Business (2020-2025)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-29O17580

Fri Sep 26 00:00:00 UTC 2025

Add to Cart

Global Neonatal Stem Cell Storage Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-38Q16325

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Stem Cell Research Antibodies Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-35K16574

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Regenerative Biological Patch Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-15B16632

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global RNA Interference Therapy Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-34C16286

Global RNA Interference Therapy Market Research Report 2025

FEATURED COMPANIES

RNA Interference Therapy Market

Scope of RNA Interference Therapy Market Report

Chapter Outline

FAQ for this report

Who are the main players in the RNA Interference Therapy Market report?

What are the Application segmentation covered in the RNA Interference Therapy Market report?

What are the Type segmentation covered in the RNA Interference Therapy Market report?

FEATURED COMPANIES

RELATED REPORTS